• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人血清和血浆中表皮生长因子的来源不同。

Human serum and plasma have different sources of epidermal growth factor.

作者信息

Lev-Ran A, Hwang D L, Snyder D S

机构信息

Department of Diabetes, Endocrinology, and Metabolism, City of Hope National Medical Center, Duarte, California 91010.

出版信息

Am J Physiol. 1990 Sep;259(3 Pt 2):R545-8. doi: 10.1152/ajpregu.1990.259.3.R545.

DOI:10.1152/ajpregu.1990.259.3.R545
PMID:2396713
Abstract

Epidermal growth factor (EGF) was determined by radioimmunoassay in serum, plasma, and urine of 23 patients undergoing ablative therapy followed by bone marrow transplantation. The difference between the serum and plasma values reflected the amount of EGF released from the platelets at the time of blood coagulation. Platelet-derived EGF strongly correlated with platelet count (r + 0.850, P less than 0.0001), and the intercept of the regression line was very close to zero; one platelet contained approximately 2.5 x 10(-18) g EGF. Correspondingly, when the platelet count dropped after bone marrow ablation from 222 +/- 97 to 33 +/- 13 x 10(9)/l, the serum EGF decreased from 603 +/- 222 to 65 +/- 41 pg/ml (P less than 0.0001). Plasma EGF content did not correlate with the platelet count and did not change significantly after bone marrow ablation (before and after the ablation, correspondingly, 290 +/- 80 and 332 +/- 99 pg/ml, P = 0.194). High-performance liquid chromatographic fractionation of serum and plasma showed different molecular mass distribution of EGF-immunoreactive fractions. The main molecular mass components of the plasma EGF did not change after bone marrow ablation. Urine excretion remained unchanged (320 +/- 133 and 314 +/- 173 pmol EGF/mmol creatinine). We conclude that whereas platelets are the source of serum EGF, the origin of plasma EGF is different and the search of its origin is warranted.

摘要

采用放射免疫分析法对23例接受骨髓移植的清髓性治疗患者的血清、血浆和尿液中的表皮生长因子(EGF)进行了测定。血清和血浆值之间的差异反映了凝血时从血小板释放的EGF量。血小板源性EGF与血小板计数密切相关(r = +0.850,P<0.0001),回归线的截距非常接近零;一个血小板约含2.5×10⁻¹⁸g EGF。相应地,骨髓消融后血小板计数从222±97降至33±13×10⁹/L时,血清EGF从603±222降至65±41 pg/ml(P<0.0001)。血浆EGF含量与血小板计数无关,骨髓消融后无显著变化(消融前后分别为290±80和332±99 pg/ml,P = 0.194)。血清和血浆的高效液相色谱分离显示EGF免疫反应性组分的分子量分布不同。骨髓消融后血浆EGF的主要分子量成分未改变。尿排泄量保持不变(320±133和314±173 pmol EGF/mmol肌酐)。我们得出结论,血小板是血清EGF的来源,而血浆EGF的来源不同,有必要对其来源进行研究。

相似文献

1
Human serum and plasma have different sources of epidermal growth factor.人血清和血浆中表皮生长因子的来源不同。
Am J Physiol. 1990 Sep;259(3 Pt 2):R545-8. doi: 10.1152/ajpregu.1990.259.3.R545.
2
Characterization of material with epidermal growth factor immunoreactivity in human serum and platelets.人血清和血小板中具有表皮生长因子免疫反应性的物质的特性分析。
J Clin Endocrinol Metab. 1989 Feb;68(2):486-91. doi: 10.1210/jcem-68-2-486.
3
Serum and plasma epidermal growth factor in thyroid disorders.甲状腺疾病中的血清和血浆表皮生长因子
Acta Endocrinol (Copenh). 1992 Jul;127(1):52-7. doi: 10.1530/acta.0.1270052.
4
Release of different fractions of epidermal growth factor from human platelets in vitro: preferential release of 140 kDa fraction.人血小板体外释放不同组分的表皮生长因子:140 kDa组分的优先释放
Regul Pept. 1992 Jan 23;37(2):95-100. doi: 10.1016/0167-0115(92)90658-h.
5
Increased content of epidermal growth factor in platelet lysates in non-insulin-dependent diabetes mellitus.非胰岛素依赖型糖尿病患者血小板裂解物中表皮生长因子含量增加。
Life Sci. 1993;53(9):717-24. doi: 10.1016/0024-3205(93)90248-2.
6
Immunoreactive epidermal growth factor in serum, plasma, platelets, and urine in patients on chronic dialysis.慢性透析患者血清、血浆、血小板及尿液中的免疫反应性表皮生长因子
Nephron. 1991;57(2):164-6. doi: 10.1159/000186244.
7
Platelet epidermal growth factor in thyroid disorders.血小板表皮生长因子与甲状腺疾病
Endocr J. 1998 Feb;45(1):83-8. doi: 10.1507/endocrj.45.83.
8
Epidermal growth factor (EGF) in serum of patients with differentiated carcinoma of thyroids.分化型甲状腺癌患者血清中的表皮生长因子(EGF)
Neoplasma. 1992;39(1):11-4.
9
Human epidermal growth factor-on molecular forms present in urine and blood.
Regul Pept. 1992 Nov 20;42(1-2):75-84. doi: 10.1016/0167-0115(92)90025-p.
10
Human plasma epidermal growth factor/beta-urogastrone is associated with blood platelets.人血浆表皮生长因子/β-尿抑胃素与血小板有关。
J Clin Invest. 1983 Jul;72(1):249-59. doi: 10.1172/jci110964.

引用本文的文献

1
Lack of Association between Epidermal Growth Factor or Its Receptor and Reflux Esophagitis, Barrett's Esophagus, and Esophageal Adenocarcinoma: A Case-Control Study.表皮生长因子及其受体与反流性食管炎、巴雷特食管和食管腺癌之间缺乏关联:一项病例对照研究。
Dis Markers. 2022 Aug 31;2022:8790748. doi: 10.1155/2022/8790748. eCollection 2022.
2
In Vitro and Ex Vivo Kinetic Release Profile of Growth Factors and Cytokines from Leucocyte- and Platelet-Rich Fibrin (L-PRF) Preparations.富白细胞纤维蛋白(L-PRF)制剂中生长因子和细胞因子的体外和体内动力学释放谱。
Cells. 2022 Jun 30;11(13):2089. doi: 10.3390/cells11132089.
3
Ticagrelor Improves Endothelial Function by Decreasing Circulating Epidermal Growth Factor (EGF).
替格瑞洛通过降低循环表皮生长因子(EGF)来改善内皮功能。
Front Physiol. 2018 Apr 6;9:337. doi: 10.3389/fphys.2018.00337. eCollection 2018.